Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2025-10-31 00:00:00 ET · period of report 2025-10-29 · accession 0001470831-25-000282 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-10-31 | 2025-10-29 | BBIO | MCCORMICK FRANK | Dir | S - Sale | $66.58 | -198.4K | 732.0K | -21% | -$13.21M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-29 | S | D | 111,755 | $65.48 | 766,583 | I By the Francis P. McCormick Rev Trust U/A DTD 1/27/2017 | — | — | (F2) Represents the weighted average sale price of the shares sold from $65.00 to $65.999 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2025-10-29 | S | D | 31,116 | $66.20 | 735,467 | I By the Francis P. McCormick Rev Trust U/A DTD 1/27/2017 | — | — | (F3) Represents the weighted average sale price of the shares sold from $66.00 to $66.9875 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2025-10-29 | S | D | 43,393 | $69.24 | 679,979 | I By the Francis P. McCormick Rev Trust U/A DTD 1/27/2017 | — | — | (F6) Represents the weighted average sale price of the shares sold from $69.00 to $69.24 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2025-10-29 | S | D | 8,598 | $68.50 | 723,372 | I By the Francis P. McCormick Rev Trust U/A DTD 1/27/2017 | — | — | (F5) Represents the weighted average sale price of the shares sold from $68.005 to $68.99 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2025-10-29 | S | D | 3,497 | $67.52 | 731,970 | I By the Francis P. McCormick Rev Trust U/A DTD 1/27/2017 | — | — | (F4) Represents the weighted average sale price of the shares sold from $67.00 to $67.996 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |